Connor, Clark & Lunn Investment Management (CC&L)’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,169
Closed -$212K 1108
2022
Q2
$212K Sell
5,169
-435
-8% -$21.1K ﹤0.01% 924
2022
Q1
$324K Sell
5,604
-1,502
-21% -$82.2K ﹤0.01% 857
2021
Q4
$418K Sell
7,106
-2,540
-26% -$154K ﹤0.01% 832
2021
Q3
$586K Sell
9,646
-2,923
-23% -$171K ﹤0.01% 740
2021
Q2
$754K Buy
12,569
+6,854
+120% +$343K ﹤0.01% 712
2021
Q1
$270K Buy
+5,715
New +$235K ﹤0.01% 881

Other funds holding ATEX

Connor, Clark & Lunn Investment Management (CC&L)'s ATEX Position: Q3 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Anterix (ATEX) in Q3 2022, closing a stake of 5,169 shares — an estimated $212K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ATEX in Q1 2021 and held it in 6 quarters. The position peaked at $754K in Q2 2021. 100 funds tracked by Wall St. Rank hold ATEX as of Q3 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Anterix position as of Q3 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 5,169 Anterix shares in Q3 2022, an estimated $212K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Anterix in Q1 2021 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Anterix position peaked at $754K in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Anterix as of Q3 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2022, filed 10 Nov 2022.